BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23624362)

  • 1. Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women.
    Blitz S; Baxter J; Raboud J; Walmsley S; Rachlis A; Smaill F; Ferenczy A; Coutlée F; Hankins C; Money D;
    J Infect Dis; 2013 Aug; 208(3):454-62. PubMed ID: 23624362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly active antiretroviral therapy and incidence of cervical squamous intraepithelial lesions among HIV-infected women with normal cytology and CD4 counts above 350 cells/mm3.
    Sirera G; Videla S; López-Blázquez R; Llatjos M; Tarrats A; Castellà E; Grane N; Tural C; Rey-Joly C; Clotet B
    J Antimicrob Chemother; 2008 Jan; 61(1):191-4. PubMed ID: 17977910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis.
    Kelly H; Weiss HA; Benavente Y; de Sanjose S; Mayaud P;
    Lancet HIV; 2018 Jan; 5(1):e45-e58. PubMed ID: 29107561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study.
    Dalstein V; Riethmuller D; Prétet JL; Le Bail Carval K; Sautière JL; Carbillet JP; Kantelip B; Schaal JP; Mougin C
    Int J Cancer; 2003 Sep; 106(3):396-403. PubMed ID: 12845680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women.
    Minkoff H; Ahdieh L; Massad LS; Anastos K; Watts DH; Melnick S; Muderspach L; Burk R; Palefsky J
    AIDS; 2001 Nov; 15(16):2157-64. PubMed ID: 11684935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology.
    Paramsothy P; Jamieson DJ; Heilig CM; Schuman PC; Klein RS; Shah KV; Rompalo AM; Cu-Uvin S; Duerr A
    Obstet Gynecol; 2009 Jan; 113(1):26-31. PubMed ID: 19104356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study.
    Moodley JR; Constant D; Hoffman M; Salimo A; Allan B; Rybicki E; Hitzeroth I; Williamson AL
    BMC Cancer; 2009 Aug; 9():275. PubMed ID: 19664216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women.
    Minkoff H; Zhong Y; Burk RD; Palefsky JM; Xue X; Watts DH; Levine AM; Wright RL; Colie C; D'Souza G; Massad LS; Strickler HD
    J Infect Dis; 2010 Mar; 201(5):681-90. PubMed ID: 20105077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Palefsky JM
    Curr Opin Oncol; 2003 Sep; 15(5):382-8. PubMed ID: 12960521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papilloma virus infection of uterine cervix and spectrum of cervical pathology in human immunodeficiency virus/AIDS.
    Jain BB; Adhikary T; Sadhukhan PC; Nandi A
    J Cancer Res Ther; 2021; 17(6):1462-1467. PubMed ID: 34916378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective cohort study to evaluate immunosuppressive cytokines as predictors of viral persistence and progression to pre-malignant lesion in the cervix in women infected with HR-HPV: study protocol.
    Torres-Poveda K; Bahena-Román M; Delgado-Romero K; Madrid-Marina V
    BMC Infect Dis; 2018 Nov; 18(1):582. PubMed ID: 30453958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and distribution of cervical high-risk human papillomavirus and cytological abnormalities in women living with HIV in Denmark - the SHADE.
    Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rønsholt FF; Johansen IS; Pedersen G; Hashemi L; Nielsen LN; Nilas L; Obel N; Bonde J; Lebech AM
    BMC Cancer; 2016 Nov; 16(1):866. PubMed ID: 27821088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association between high-risk human papillomavirus DNA load and different histological grades of cervical neoplasia].
    Zhao FH; Hu SY; Wang SM; Chen F; Zhang X; Zhang WH; Pan QJ; Qiao YL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):565-70. PubMed ID: 19954065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy.
    De Vuyst H; Lillo F; Broutet N; Smith JS
    Eur J Cancer Prev; 2008 Nov; 17(6):545-54. PubMed ID: 18941376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents.
    Shrestha S; Sudenga SL; Smith JS; Bachmann LH; Wilson CM; Kempf MC
    BMC Infect Dis; 2010 Oct; 10():295. PubMed ID: 20946655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A longitudinal study of HPV detection and cervical pathology in HIV infected women.
    Cubie HA; Seagar AL; Beattie GJ; Monaghan S; Williams AR
    Sex Transm Infect; 2000 Aug; 76(4):257-61. PubMed ID: 11026879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between cocaine use and human papillomavirus infections in HIV-seropositive and HIV-seronegative women.
    Minkoff H; Zhong Y; Strickler HD; Watts DH; Palefsky JM; Levine AM; D'Souza G; Howard AA; Plankey M; Massad LS; Burk R
    Infect Dis Obstet Gynecol; 2008; 2008():587082. PubMed ID: 18437233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection.
    Yamada R; Sasagawa T; Kirumbi LW; Kingoro A; Karanja DK; Kiptoo M; Nakitare GW; Ichimura H; Inoue M
    J Med Virol; 2008 May; 80(5):847-55. PubMed ID: 18360898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term follow up of cervical squamous intraepithelial lesions associated with HIV and human papillomavirus infections in Africa.
    La Ruche G; Leroy V; Mensah-Ado I; Ramon R; You B; Bergeron C; Mothebesoane-Anoh S; Touré-Coulibaly K; Dabis F
    Int J STD AIDS; 1999 Jun; 10(6):363-8. PubMed ID: 10414878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women.
    Tornesello ML; Duraturo ML; Giorgi-Rossi P; Sansone M; Piccoli R; Buonaguro L; Buonaguro FM
    J Gen Virol; 2008 Jun; 89(Pt 6):1380-1389. PubMed ID: 18474553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.